CLINICAL_TRIALS
trial_result
· 2021-04-28
Clinical Trial Update: Pan European Collaboration on Antipsychotic Naïve Schizophrenia II [Phase 4]
Summary
Phase 4 clinical trial update on antipsychotic naïve schizophrenia from a pan-European collaboration; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Copenhagen | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED